APC and colorectal cancer: The constitutive activation of this pathway is thought to be the initiating event in colorectal cancer, with such activation occurring mainly as a result of mutation of APC (adenomatous polyposis coli gene) and consequent inhibition of GSK-3β-dependent phosphorylation of the β-catenin phosphodegron.